Cultured blood T‐cell responses predict anti‐TNF therapy response in patients with ulcerative colitis

E-ISSN： 1365-2036|41|11|1149-1161

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.11, 2015-06, pp. : 1149-1161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: applying pharmacokinetics to optimise dosing of anti‐TNF biologics in acute severe ulcerative colitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1094-1103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the Greek Population

By Vasilopoulos Yiannis

Molecular Diagnosis & Therapy, Vol. 16, Iss. 1, 2012-02 ,pp. : 29-34

Adis International

Access to resources Recommend Favorite

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serology and ulcerative colitis behavior

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 64-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 6, 2015-06 ,pp. : 659-666

John Wiley & Sons Inc

Access to resources Recommend Favorite